Apple Watch Adds Blood Pressure Alerts with AI-Powered Technology
PorAinvest
viernes, 19 de septiembre de 2025, 1:51 pm ET1 min de lectura
AAPL--
The new feature uses the watch’s optical heart sensor to analyze blood vessel responses to heartbeats. Running passively in the background, the algorithm reviews data collected over 30 days and notifies users if it detects consistent signs of high blood pressure. Apple noted that the tool may not identify every case of hypertension but could alert around one million users globally. The company plans to roll out the technology in more than 150 countries and regions, including the U.S. and the EU [1].
According to analysts, the introduction of this AI-driven feature has sparked interest among investors. Market analysts have been assessing Apple's prospects, with the average one-year price target for Apple Inc. (AAPL, Financial) standing at $243.48, including a high estimate of $305.00 and a low estimate of $175.00. These projections suggest a modest upside of 2.35% from the present stock price of $237.88, indicating potential for growth. The consensus recommendation from 50 brokerage firms is an average rating of 2.1, classifying Apple as an "Outperform" stock [2].
While the new feature is aimed at helping individuals identify high blood pressure early, experts stress that it should not replace a doctor's diagnosis. The feature is designed to complement traditional medical practices and provide users with additional data points to discuss with healthcare professionals.
Apple has added a new health feature to its Watch Series 11, which uses AI to warn users when they may have high blood pressure. The feature analyzes existing heart sensor data and will be available in over 150 countries. It is aimed at helping individuals identify high blood pressure early, but experts stress that it should not replace a doctor's diagnosis.
The U.S. Food and Drug Administration (FDA) has authorized Apple (AAPL.O) to launch a new hypertension detection feature on its smartwatches, the company said late Friday. Apple unveiled the blood pressure monitoring capability during its September 9 event, where it also introduced a slimmer iPhone Air and updated iPhone lineup. The feature will be available later this month on the Apple Watch Series 9, Series 10, Series 11, and the premium Ultra 2 and Ultra 3 models [1].The new feature uses the watch’s optical heart sensor to analyze blood vessel responses to heartbeats. Running passively in the background, the algorithm reviews data collected over 30 days and notifies users if it detects consistent signs of high blood pressure. Apple noted that the tool may not identify every case of hypertension but could alert around one million users globally. The company plans to roll out the technology in more than 150 countries and regions, including the U.S. and the EU [1].
According to analysts, the introduction of this AI-driven feature has sparked interest among investors. Market analysts have been assessing Apple's prospects, with the average one-year price target for Apple Inc. (AAPL, Financial) standing at $243.48, including a high estimate of $305.00 and a low estimate of $175.00. These projections suggest a modest upside of 2.35% from the present stock price of $237.88, indicating potential for growth. The consensus recommendation from 50 brokerage firms is an average rating of 2.1, classifying Apple as an "Outperform" stock [2].
While the new feature is aimed at helping individuals identify high blood pressure early, experts stress that it should not replace a doctor's diagnosis. The feature is designed to complement traditional medical practices and provide users with additional data points to discuss with healthcare professionals.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios